Market evolution: Anaesthetic machines (CN 90189060) — 2015–2025

Introduction

This report analyses the evolution of the European Union's external trade in anaesthetic apparatus and instruments (customs code 90189060) over the period from 2015 to 2025. The data reveals a decade of significant transformation, characterized by a widening trade deficit, a major geographic reorientation of trade flows, and growing external reliance, all against a backdrop of rising unit values and shifting market concentration. The analysis is based on annual trade statistics between the EU and non-EU countries.

You can explore the full trade overview on the dashboard here.

1. A Widening Deficit Driven by High-Value Imports

The most striking feature of the period is the dramatic shift in the EU's trade balance. While both imports and exports grew in value, imports expanded at a much faster rate, leading to a substantial and persistent trade deficit.

The import surge outpaced export growth

The EU's total import value for anaesthetic apparatus grew by 51.8%, rising from €451 million in 2015 to €685 million in 2025. In contrast, export value grew by 10.2%, from €387 million to €426 million over the same period. This divergence caused the trade deficit to worsen significantly. The EU moved from a deficit of €65 million in 2015 to a deficit of €259 million in 2025, a deterioration of over 300%. The deficit peaked at €333 million in 2020.

Trade volumes stagnated while unit values soared

Interestingly, the growth in trade values occurred despite a stagnation or decline in physical volumes. Import quantities fell by 4.2% (from 6,317 tonnes to 6,054 tonnes), and export quantities fell by 5.2% (from 2,302 tonnes to 2,181 tonnes). The key driver was a sharp increase in unit values (price per tonne). Import prices rose by 58.3%, reaching €113,085 per tonne in 2025, while export prices increased by 16.3% to €195,245 per tonne. This indicates a trend towards importing higher-value equipment and potentially a shift in the EU's export profile towards even more specialized, premium-priced products.

EU production shifted towards higher value

EU production data corroborates this value-added trend. Between 2015 and 2025, the reported production quantity of anaesthetic items within the EU fell by 50% (from 60 million to 30 million pieces). However, the total value of EU production increased by 174% over the same period, rising from €157 million to €430 million. This confirms a strategic move within the EU's own manufacturing base away from high-volume, potentially lower-value production towards higher-value-added output.

2. A Fundamental Geographic Reorientation of Trade Partners

The period saw a major reshuffling of the EU's most important trading partners for this product category, both in terms of imports and exports, altering the market's structural dependencies.

Import origins: The rise of Mexico and China, the decline of the United States

In 2015, the United States was the EU's largest source of imports (€266 million), but its share fell by 23.4% to €204 million by 2025. The vacuum was filled by two key partners:

Mexico became the dominant import source, with its share exploding by 511% from €55 million in 2015 to €336 million in 2025. This is the single largest shift in the trade data.
China also grew significantly, with imports increasing by 43.7% to €48 million.

This reorientation reduced the import concentration from the US and diversified the supply base, though towards Mexico.

You can explore the full list of top import partners here.

Export destinations: Consolidation around the United States

On the export side, the United States solidified its position as the EU's primary customer. Its share of EU exports more than doubled, growing by 115% from €62 million to €134 million. Meanwhile, exports to several other major partners declined: exports to the United Kingdom fell by 43.3%, to Russia by 39.4%, and to China by 38.4%. This led to a higher concentration of EU exports directed towards the US market.

Shifts in market concentration

The Herfindahl-Hirschman Index (HHI) measures market concentration. The HHI for EU imports decreased by 10.7% over the period, reflecting a move from a more concentrated import market (reliant on the US) to a slightly more diversified one (though still led by Mexico). Conversely, the HHI for EU exports increased by 30%, indicating growing concentration as exports focused on fewer key partners, primarily the US.

3. Increased External Reliance and Market Instability

The combination of rising import values and shifting trade flows has left the EU more reliant on external sources for anaesthetic apparatus, while the market experienced periods of notable price volatility and shocks.

Import reliance more than doubled

The net import reliance, a key indicator of strategic dependency, increased dramatically. It rose from 14.8% in 2015 to 38.1% in 2025, a 157% increase. This metric captures the degree to which EU consumption is met by imports, confirming a significant increase in the bloc's vulnerability to external supply disruptions in this medical equipment sector.

Significant price volatility, especially from Mexico

Variance analysis shows that import prices from several partners were highly volatile. Notably, import prices from Mexico—the EU's now-largest supplier—were very volatile (Coefficient of Variation of 0.40), and a major price shock was detected in 2019, where abnormal price movements coincided with a massive surge in import value share. This suggests potential pricing instability or compositional shifts in trade with this critical partner. On the export side, the EU saw price shocks when exporting to South Korea (2023) and Japan (2021).

Within the EU, Germany remains the top exporter

The internal EU market structure shows that Germany is by far the leading exporter within the bloc, accounting for the largest share of EU exports to non-EU countries and increasing its lead over the period. The Netherlands is the most specialized EU member state in this product, with a high Revealed Symmetric Comparative Advantage (RSCA), but it does not dominate the total export volume.

Conclusion

Over the decade to 2025, the EU's market for anaesthetic apparatus transformed from one of near-balance into a structurally import-dependent market. This shift was characterized by three core dynamics: a steep rise in the value of imports that far outpaced exports, a fundamental reorientation of import supply chains away from the US and towards Mexico, and a consequent doubling of the EU's external reliance. While EU production and export values grew, suggesting a focus on high-value niches, the overall deficit widened. The increased reliance on a volatile import market, particularly from Mexico, poses questions about supply chain resilience for critical medical equipment. The data points to an EU that is a significant consumer and high-end producer in this sector, but one whose net external dependency has grown substantially.